Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 06-2025 | 03-2025 | |
| Sales | 6,314 | 7,224 | 0 | 10,130 | 8,818 |
| Gross Profit | 6,314 | 7,224 | N/A | 10,130 | 8,818 |
| Operating Expenses | 77,928 | 71,336 | 0 | 70,280 | 56,972 |
| Operating Income | -71,614 | -64,112 | N/A | -60,150 | -48,154 |
| Interest Expense | 155 | 182 | 0 | 307 | 368 |
| Other Income | 4,567 | 2,608 | 0 | 3,759 | 4,264 |
| Pre-tax Income | -67,202 | -61,686 | 0 | -56,698 | -44,258 |
| Income Tax | 53 | 28 | N/A | 44 | 56 |
| Net Income Continuous | -67,255 | -61,714 | N/A | -56,742 | -44,314 |
| Minority Interests | N/A | -268 | N/A | -4,313 | -2,629 |
| Net Income | $-67,255 | $-61,446 | $N/A | $-52,429 | $-41,685 |
| EPS Basic Total Ops | -0.52 | -1.07 | N/A | -1.94 | -1.62 |
| EPS Basic Continuous Ops | -0.52 | -0.95 | N/A | -1.72 | -1.35 |
| EPS Diluted Total Ops | -0.52 | -1.07 | N/A | -1.94 | -1.62 |
| EPS Diluted Continuous Ops | -0.52 | -0.95 | N/A | -1.72 | -1.35 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.07 | N/A | N/A | N/A |
| EBITDA(a) | $-68,777 | $-60,985 | $N/A | $-57,623 | $-45,659 |